Redcare Pharmacy NV
F:RDC

Watchlist Manager
Redcare Pharmacy NV Logo
Redcare Pharmacy NV
F:RDC
Watchlist
Price: 62.85 EUR -2.93%
Market Cap: 1.1B EUR

Redcare Pharmacy NV
Investor Relations

Redcare Pharmacy NV, rooted in the heart of Europe, has been revolutionizing the way people access healthcare with its robust e-commerce platform. Born from the union of healthcare and technology, Redcare Pharmacy serves as an online apothecary catering to the modern consumer's need for convenience and efficiency. The company thrives in a digital ecosystem, offering an extensive catalog of pharmaceuticals, wellness products, and personal care items, all easily accessible with a few clicks. This seamless interaction with consumers is facilitated through a state-of-the-art logistics network, ensuring a swift and reliable delivery service that meets the demands of a fast-paced world. The infrastructure not only supports a vast inventory but also allows for personalized shopping experiences, often driven by data analytics and customer insights, which are critical in maintaining a loyal clientele.

At the core of Redcare Pharmacy’s business model is its ability to leverage technology to drive sales and customer satisfaction while maintaining cost efficiency. By bypassing the traditional brick-and-mortar pharmacy setup, the company significantly reduces overhead costs, thereby allowing them to offer competitive pricing. Revenue flows not just from direct sales of medical and lifestyle products, but also through strategic partnerships and collaborations with pharmaceutical companies and healthcare providers who rely on Redcare's platform to reach a broader audience. Furthermore, the company taps into multiple streams of income by providing digital health consultations, assimilating telehealth services into their offerings. Through these innovative approaches, Redcare Pharmacy NV sustains a profitable ecosystem, balancing consumer needs with cutting-edge digital solutions in a rapidly evolving healthcare landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 29, 2025
AI Summary
Q3 2025

Strong Sales Growth: Group sales rose 27% year-over-year for the first 9 months, driven by both Rx and non-Rx segments, with particularly fast growth in Germany.

Rx Expansion: German Rx sales surged 122% YoY, and the company has increased market share in this segment to 0.94%, with e-script market share at 1.19%.

Margin Improvement: Adjusted EBITDA margin reached 2.1% for the year-to-date and 2.4% in Q3, both within full-year guidance.

Cash Flow & Funding: Operating cash flow remains strong and positive, even with significant Rx marketing spend, and the company is fully funded for current and upcoming investments.

Guidance Confirmed: Management reiterated guidance: sales growth of over 25% for the full year, non-Rx growth above 18%, and an adjusted EBITDA margin between 2% and 2.5%.

Operational Investments: Major logistics investments are on track and fully funded, with the new Pilsen site operational and automation in Sevenum progressing.

Competition & Strategy: Management remains confident in its online pharmacy positioning despite reports of new entrants in the German OTC market.

Key Financials
Sales (Q3)
EUR 790 million
Sales (9 months YTD)
EUR 2.15 billion
Adjusted EBITDA (Q3)
EUR 17 million
Adjusted EBITDA (9 months YTD)
EUR 44 million
Adjusted EBITDA margin (Q3)
2.4%
Adjusted EBITDA margin (9 months YTD)
2.1%
Cash (end of September)
EUR 266 million
German Rx Market Share (Q3 annualized)
0.94%
German Rx Sales (Q3 annualized)
EUR 520 million
Non-Rx Growth
up 18% YoY
Repeat Order Rate
90%
Net Promoter Score (NPS)
72
Operating Cash Flow (rolling, excl. Rx Germany)
EUR 100 million
Operating Cash Flow (rolling, total company)
EUR 32.8 million
Other Earnings Calls

Management

Mr. Olaf Heinrich
CEO & Member of the Managing Board
No Bio Available
Mr. Marc Fischer
Co-Founder & Advisor
No Bio Available
Ms. Theresa Holler
COO & Member of the Managing Board
No Bio Available
Mr. Dirk Bruse
Chief Commercial Officer & Member of Management Board
No Bio Available
Mr. Lode Fastré
Chief Information Officer & Member of Management Board
No Bio Available
Mr. Patrick Schneider
Chief Sales Officer
No Bio Available
Ms. Beate Krosch
Director of Human Resources
No Bio Available
Mr. Nana Lohmanns
Chief E-Health Officer
No Bio Available
Mr. Jens Wolfgarten
Chief Product Officer - Retail
No Bio Available

Contacts

Address
LIMBURG
Sevenum
Erik de Rodeweg 11/13
Contacts